Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Current Topics in Medicinal Chemistry
|
April 28, 2005
Small molecule inhibitors of p53/MDM2 interaction
Nader Fotouhi, Bradford Graves
Expert Opinion on Drug Discovery
|
March 19, 2013
Lead generation: reality check on commonly held views
Nader Fotouhi, Paul Gillespie, Robert Goodnow
Current Topics in Medicinal Chemistry
|
November 17, 2004
The discovery of VLA-4 antagonists
Jefferson W Tilley, Li Chen, Achyutharao Sidduri, et al.
Antimicrobial Agents and Chemotherapy
|
February 2, 2021
Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant <i>Rv0678</i> Mutant in a Mouse Model of Tuberculosis
Jian Xu, Paul J Converse, Anna M Upton, et al.
Antimicrobial Agents and Chemotherapy
|
September 27, 2021
Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant <i>Rv0678</i> Mutant in a Mouse Model of Tuberculosis
Deepak Almeida, Paul J Converse, Si-Yang Li, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2023
Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis
Deepak Almeida, Si-Yang Li, Jin Lee, et al.
Nature Reviews. Drug Discovery
|
May 15, 2024
Combating antimicrobial resistance in malaria, HIV and tuberculosis
Maëlle Duffey, Robert W Shafer, Juliano Timm, et al.
Antimicrobial Agents and Chemotherapy
|
April 27, 2021
Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis
Rokeya Tasneen, Deborah S Mortensen, Paul J Converse, et al.
Antimicrobial Agents and Chemotherapy
|
March 15, 2023
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model
Si-Yang Li, Paul J Converse, Fabrice Betoudji, et al.
The Journal of Infectious Diseases
|
June 28, 2024
Relative Contributions of the Novel Diarylquinoline TBAJ-876 and its Active Metabolite to the Bactericidal Activity in a Murine Model of Tuberculosis
Saskia E Mudde, Nicole C Ammerman, Marian T Ten Kate, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Current Topics in Medicinal Chemistry
|
April 28, 2005
Small molecule inhibitors of p53/MDM2 interaction
Nader Fotouhi, Bradford Graves
Expert Opinion on Drug Discovery
|
March 19, 2013
Lead generation: reality check on commonly held views
Nader Fotouhi, Paul Gillespie, Robert Goodnow
Current Topics in Medicinal Chemistry
|
November 17, 2004
The discovery of VLA-4 antagonists
Jefferson W Tilley, Li Chen, Achyutharao Sidduri, et al.
Antimicrobial Agents and Chemotherapy
|
February 2, 2021
Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant <i>Rv0678</i> Mutant in a Mouse Model of Tuberculosis
Jian Xu, Paul J Converse, Anna M Upton, et al.
Antimicrobial Agents and Chemotherapy
|
September 27, 2021
Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant <i>Rv0678</i> Mutant in a Mouse Model of Tuberculosis
Deepak Almeida, Paul J Converse, Si-Yang Li, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2023
Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis
Deepak Almeida, Si-Yang Li, Jin Lee, et al.
Nature Reviews. Drug Discovery
|
May 15, 2024
Combating antimicrobial resistance in malaria, HIV and tuberculosis
Maëlle Duffey, Robert W Shafer, Juliano Timm, et al.
Antimicrobial Agents and Chemotherapy
|
April 27, 2021
Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis
Rokeya Tasneen, Deborah S Mortensen, Paul J Converse, et al.
Antimicrobial Agents and Chemotherapy
|
March 15, 2023
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model
Si-Yang Li, Paul J Converse, Fabrice Betoudji, et al.
The Journal of Infectious Diseases
|
June 28, 2024
Relative Contributions of the Novel Diarylquinoline TBAJ-876 and its Active Metabolite to the Bactericidal Activity in a Murine Model of Tuberculosis
Saskia E Mudde, Nicole C Ammerman, Marian T Ten Kate, et al.
Page
of 4